Q1 Fiscal Year 2025 
- Excellent equipment book-to-bill ratio of 1.21 
 - Comparable revenue growth of 5.7% 
 - Imaging comparable revenue growth of 7.6%; adjusted EBIT margin of 18.7% impacted by special items 
 - Diagnostics comparable revenue growth of 1.6%; adjusted EBIT margin of 7.8% 
 - Varian comparable revenue growth of 6.2%; adjusted EBIT margin of 17.1% 
 - Advanced Therapies comparable revenue growth of 5.1%; adjusted EBIT margin of 14.1% 
 - Overall adjusted EBIT margin of 15.0%, above prior-year quarter 
 - Free cash flow of around 鈧810 million, more than tripled from prior-year quarter 
 - Adjusted basic earnings per share of 鈧0.51, above prior-year quarter 
 
Outlook for Fiscal Year 2025 
We confirm our expectation of comparable revenue growth of between 5% to 6% compared with fiscal year 2024 and adjusted basic earnings per share of between 鈧2.35 and 鈧2.50. 
Bernd Montag, CEO of Siemens Healthineers AG: 
鈥漌e have made a strong start to the year. Our performance is consistently improving from a high base thanks to the efforts of the whole Healthineers team.鈥